Melinta Therapeutics, Inc. (NASDAQ: MLNT) announced that its Board of Directors has approved a one-for-five reverse stock ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE